NI
HRTX icon

Numeric Investors’s Heron Therapeutics HRTX Stock Holding History

Numeric Investors’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-16,600
Closed -$315K – 1082
2016
Q1 		$315K Buy
+16,600
New +$328K ﹤0.01% 848
2015
Q4 		– Sell
-23,000
Closed -$561K – 1042
2015
Q3 		$561K Buy
+23,000
New +$766K 0.01% 672

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Numeric Investors's HRTX Position: Q2 2016 in Review

Numeric Investors sold out of Heron Therapeutics (HRTX) in Q2 2016, closing a stake of 16,600 shares — an estimated $315K sold.

Numeric Investors first reported a position in HRTX in Q3 2015 and held it in 2 quarters. The position peaked at $561K in Q3 2015. 92 funds tracked by Wall St. Rank hold HRTX as of Q2 2016.

  • Numeric Investors reported no remaining Heron Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Numeric Investors sold 16,600 Heron Therapeutics shares in Q2 2016, an estimated $315K.
  • Numeric Investors first reported a position in Heron Therapeutics in Q3 2015 and held it in 2 quarters.
  • Numeric Investors's Heron Therapeutics position peaked at $561K in Q3 2015.
  • 92 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2016.

Based on Numeric Investors's 13F filing for Q2 2016, filed 16 Aug 2016.